Abbott acquires medical tests maker Alere for US$5.8 billion
New York
ABBOTT said on Monday that it had agreed to acquire Alere for an expected US$5.8 billion to enhance its diagnostics business.
Alere, which had a market value of US$3.2 billion last Friday, makes "point of care" medical tests that can provide results in a matter of minutes. The company, based in Waltham, Massachusetts, will become a subsidiary of Abbott, which is expecting to have annual diagnostic sales of US$7 billion after the transaction closes, according to a statement released by the companies on Monday. "We want to offer our customers the best and broadest diagnostics solutions," Miles White, chairman and chief executive of Abbott, said. "Alere helps us do that."
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Billionaire Geiger is said to near US$7 billion L’Occitane buyout
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years